Abstract
Investigating the proportion of depression and anxiety in patients with pulmonary nodules (PNs) and exploring the factors influencing them may help to optimize PNs management protocols and guide clinical decision-making. This study employed a cross-sectional design and included 260 patients attending the hospital’s outpatient clinic. The assessment of depression and anxiety in patients with PNs was conducted using the Hamilton Depression Scale (HAMD) and the Hamilton Anxiety Scale (HAMA), respectively. Demographic and clinical data were also collected. The factors influencing depression and anxiety in patients with PNs were analyzed using univariate analysis and binary logistic regression. The proportion of depression and anxiety in patients with PNs was 23.46% and 31.54%, respectively. The results of the binary logistic regression analysis indicated that insomnia (odds ratio [OR] = 7.343, 95%CI: 3.231–16.687) and loss of appetite (OR = 3.432, 95%CI: 1.474–7.991) were identified as independent risk factors for depression. The history of occupational exposure (OR = 4.154, 95%CI: 1.089–15.844), insomnia (OR = 4.162, 95% CI: 2.119–8.175), loss of appetite (OR = 2.326, 95%CI: 1.013–5.341), and chest tightness (OR = 3.155, 95% CI: 1.392–7.149) were significant independent predictors of anxiety. This study demonstrates that depression and anxiety are common with PNs in traditional Chinese medicine hospital. Insomnia and loss of appetite are independent risk factors for depression. History of occupational exposure, insomnia, loss of appetite, and chest tightness are independent risk factors for anxiety. Therefore, medical workers should pay close attention to the mood changes of these high-risk patients.
Similar content being viewed by others
Introduction
Pulmonary nodules (PNs) are defined as hyperdense solid or subsolid lung shadows on imaging, with a diameter of ≤ 3 cm and a focal, round-like appearance. PNs may be isolated or multiple and are not accompanied by pulmonary atelectasis, hilar lymph node enlargement, or pleural effusion1. In recent years, there has been a notable rise in the detection rate of PNs due to heightened healthcare awareness and the growing popularity of low-dose computed tomography (LDCT) screening. This trend has given rise to considerable concern2.
The pathological diagnosis of PNs includes lung cancer. However, most PNs are benign, whether identified through screening or incidentally3,4,5. In the majority of cases, medical practitioners advise patients to undergo regular follow-up with LDCT. A PET-CT scan, biopsy, or surgical resection is undertaken only if the PNs have a malignant tendency1. However, the possibility of PNs progression during follow-up is perceived by patients as a “near-cancer” experience6,7,8. The experience has been demonstrated to cause significant psychological harm to the patient, which in turn has been shown to have a marked effect on the quality of life. Among the psychological burdens commonly experienced are depression and anxiety9;10. Moreover, due to a lack of understanding of PNs, patients’ inaccurate self-diagnosis often precedes professional assessment, which may also lead to depression and anxiety11,12,13. Research confirms that patients with depression and anxiety are frequently treated more aggressively than other patients, including high-frequency CT scans14. This phenomenon not only increases the burden on the healthcare system and results in a waste of medical resources, but also leads to increased radiation exposure and the risk of cancer15,16. At the same time, repeated examinations can intensify the patient’s state of depression and anxiety17. It is worth noting that long-term depression and anxiety can inhibit the immune function of patients18,19,20. Multiple meta-analyses further revealed that it was significantly associated with increased risk of lung cancer, worse prognosis, and increased mortality15;16. Therefore, research on depression and anxiety in PNs is of great importance to optimize PNs management plans and guide clinical decision-making. However, there is currently limited research on depression and anxiety in PNs. This study aims to assess the prevalence of depression and anxiety among PNs attending traditional Chinese medicine (TCM) hospital outpatient clinics using an internationally recognized scale and to determine the risk factors associated with depression and anxiety by collecting multidimensional information.
Methods
Participants
This study employed a cross-sectional design. Participants were recruited from the outpatient clinic of Guang’anmen hospital between 1 January and 31 December 2023. All participants provided informed consent before involvement in the study. Regarding the diagnostic criteria for PNs, we referred to the “Chinese expert consensus on the diagnosis and treatment of pulmonary nodules (2018 version)”1. The classification of hazard levels is based on the “China National Guideline of Classification, Diagnosis and Treatment for Lung Nodules (2016 Version)”21. The inclusion criteria were as follows: (1) the presence of PNs diagnosed by imaging, (2) the age range of 18 to 85 years, and (3) the ability to complete the questionnaire. The exclusion criteria were as follows: (1) diagnosis or history of malignant disease, (2) diagnosis or history of psychiatric disorders, or (3) an inability to comprehend the informed consent form and a refusal to sign it.
Measurements
The proposal was approved by the Ethics Committee of Guang’anmen Hospital, China Academy of Chinese Medical Sciences (reference number: 2021-072-KY). The study was conducted in compliance with the Declaration of Helsinki. All patients used standardized assessment procedures. Potential participants were invited to participate in the study at the outpatient clinic. After the patients’ consent, the research group and the psychological evaluators interviewed the patients using a structured questionnaire. Firstly, the inclusion criteria and exclusion criteria for patients were determined. Secondly, the method and purpose of the study were explained to patients. Finally, after patients signed the informed consent, their information was collected. Demographic data and clinical data were collected by the research group. Our research group is composed of medical staff. They received systematic training before the study began. All depression and anxiety assessments were completed by psychological evaluators who did not know the study design and received standardized training. In the imaging information section, the research group will collect CT films of patients. Two experienced oncologists (Attending physician or associate chief physician) will evaluate the imaging information required for the study based on the same criteria using film. If the assessment results are inconsistent, a consensus will be reached through discussion with the third doctor (chief physician).
The data collected was divided into three sections. The first section comprised the patient’s demographic and clinical data, including name, gender, age, smoking history, history of occupational exposure (chemical exposure, radiation exposure, toxic exposure, etc.), family history of malignant tumor, body mass index (BMI), imaging data (included the number of PNs, the size of PNs, and the presence of malignant signs). Malignant signs in the imaging presentation of PNs included one or more of the following: lobulation, irregular morphology, burr sign, vacuole sign, pleural depression sign, and vascular cluster sign1. These variables have been employed in previous studies22;23. The relationship between these factors and depression/anxiety remains the subject of ongoing research, with no consensus yet reached among the academic community. Further analysis is required to elucidate the complex interplay between these variables. To analyse the correlation between depression, anxiety and clinical symptoms, six common clinical symptoms were added to the study, including cough, chest tightness, shortness of breath, insomnia, palpitation, and loss of appetite24;25. The clinical symptoms were assessed using the “Guidelines for Clinical Research of Traditional Chinese Drug Research”26.
In the second part, the Hamilton Depression Scale (HAMD) was employed to assess the depression state of the patients27. HAMD was a 17-item scale. The severity of depression was gauged by the frequency and intensity of the patient’s symptoms over the past week. Each item was classified into one of five levels or three levels, with 0 to 4 points assigned to five levels and 0 to 2 points assigned to three levels, respectively. The scores for each item were aggregated to obtain the total score for the scale, which was indicative of the severity of depression. The scale was divided as follows: no depression (0–7); mild depression (8–16); moderate depression (17–23); and severe depression (≥ 24)28.
In the third part of the study, the anxiety state of the patients was evaluated using the Hamilton Anxiety Scale (HAMA)29. HAMA was a 14-item scale. The severity of anxiety was gauged by the frequency and intensity of the patient’s symptoms over the past week. Each item was classified into one of five levels, with a score ranging from 0 to 4. The scores for each item were summed to obtain the total score for the scale. The total score was indicative of the severity of anxiety. The scale was divided as follows: no/minimal anxiety (0–7); mild anxiety (8–14); moderate (15–23); severe (≥ 24)30.
The selection of HAMD and HAMA was based on the following reasons: (1) HAMD and HAMA are authoritative scales for assessing depression and anxiety and are widely used in clinical practice31;32. (2) HAMD and HAMA are scales used by professionals, which can reduce subjective bias33.
Statistical analyses
The statistical analyses were conducted using the IBM SPSS Statistics 26.0 software. The patient’s demographic and clinical data were subjected to descriptive analysis. The counting data were described as frequencies and percentages. The normally distributed quantitative data were described as mean and standard deviation (‾X ± S) and the others by median and associated interquartile range (M (P25, P75)). In univariate analysis, the counting data were analyzed using either the chi-square test or Fisher’s exact probability method. The normally distributed quantitative data were analyzed using the t-test and the others using the Mann–Whitney U test. The multivariate analysis was conducted using binary logistic regression. The objective was to assess independent associations regarding depression and anxiety. P value < 0.05 was considered statistically significant.
Result
Characteristics of all participants
A total of 269 patients agreed to participate in this study. 9 patients were excluded due to incomplete data. A total of 260 patients completed informed consent and information collection, with a response rate of 96.7%. Based on a screening study of depression in patients with PNs (depression accounted for 19.4%), a sample size of 255 cases was calculated using PASS 15 software at α = 0.05 and an allowable error of 5%. Considering the 5% invalid questionnaire, at least 269 patients were included. Therefore, the sample size of this study meets the requirements.
Among the 260 survey responses, 66.15% were female participants and the rest were male (33.85%). The age of patients was mainly middle-aged and elderly (83.46%). The average BMI was 24.17 ± 2.95. In addition, 13.85% of the patients smoked, 5.77% of the patients had a history of occupational exposure, and 36.54% of the patients had a family history of malignant tumour. In terms of imaging information, the classification of hazard levels of patients included was mainly medium risk (69.23%). Table 1 describes the characteristics of the included patients.
Proportion of depression and anxiety of PNs
Of the 260 patients with PNs, 53 (20.38%) had mild depression, 6 (2.31%) had moderate depression, and 2 (0.78%) had severe depression. Therefore, a total of 61 patients (23.46%) were considered to have depression. There were 60 (23.08%) classified as mild anxiety, 18 (6.92%) classified as moderate anxiety, and 4 (1.54%) classified as severe anxiety. So, a total of 82 patients (31.54%) were identified as anxiety. (Fig. 1)
Univariate analysis of factors in depression and anxiety
The univariate analysis results of depression showed significant differences in variables such as cough (χ2 = 5.848, P = 0.016), chest tightness (χ2 = 31.740, P < 0.001), shortness of breath (χ2 = 29.042, P < 0.001), insomnia (χ2 = 37.902, P < 0.001), palpitation (χ2 = 25.243, P < 0.001), and loss of appetite (χ2 = 17.377, P < 0.001). (Table 2) The results of the univariate analysis for anxiety demonstrated significant differences in several variables, including the history of occupational exposure (χ2 = 5.972, P = 0.015), cough (χ2 = 7.725, P = 0.005), chest tightness (χ2 = 51.377, P < 0.001), shortness of breath (χ2 = 39.646, P < 0.001), insomnia (χ2 = 29.570, P < 0.001), palpitation (χ2 = 34.308, P < 0.001), and loss of appetite (χ2 = 11.031, P = 0.001). (Table 3) There were no significant differences in the distribution of depression and anxiety among gender, age, BMI, smoking history, family history of malignant tumour, size of PNs, number of PNs, malignant signs, and classification of hazard levels. (Tables S1, S2)
Multivariate analysis of factors in depression and anxiety
Following the univariate analyses, binary logistic regression analyses were performed on the screened variables. Figure 2 illustrates the significant related factors of depression and anxiety. The results showed that insomnia (odds ratio [OR] = 7.343, 95%CI: 3.231–16.687) and loss of appetite (OR = 3.432, 95%CI: 1.474–7.991) were identified as independent risk factors for depression. The history of occupational exposure (OR = 4.154, 95%CI: 1.089–15.844), insomnia (OR = 4.162, 95% CI: 2.119–8.175), loss of appetite (OR = 2.326, 95%CI: 1.013–5.341), and chest tightness (OR = 3.155, 95% CI: 1.392–7.149) were significant independent predictors of anxiety.
Discussion
The aim of this study was to measure the proportion of depression and anxiety in outpatients with PNs and to explore the related factors associated with depression and anxiety. We recruited patients with PNs who were first seen at an outpatient clinic in 2023. It was found that the proportion of depression and anxiety accounted for 23.46% and 31.54%, respectively.
Regarding the prevalence of depression and anxiety, Xiao R et al. employed the Hospital Anxiety and Depression Scale (HADS) to assess psychological distress in a cohort of 334 patients with PNs. Their findings revealed that 14.67% of the patients screened positive for depression and 17.96% for anxiety14. Zhuang W et al. employed the HADS to identify instances of depression and anxiety among patients with PNs. The results demonstrated that 1185 patients with PNs displayed depression in 27.0% of cases and anxiety in 42.1% of cases9. The results obtained by Li L et al. using the HADS fell within the middle range, with depression and anxiety accounting for 19.4% and 31.8% respectively34. Furthermore, some studies utilized the Patient Health Questionnaire-9 (PHQ-9) and the Generalised Anxiety Disorder-7 (GAD-7) to screen for depression and anxiety in patients with PNs. The results demonstrated a prevalence of 29.73% for depression and 28.86% for anxiety35. The study was conducted primarily in the outpatient clinics of TCM hospitals. HAMD and HAMA were employed in our investigation. HAMD represented the gold standard for rating depression31;36whereas HAMA was one of the most frequently utilized instruments for assessing anxiety in clinical settings32. This represents the authority and universality of HAMA and HAMD. Specifically, the HAMD and HAMA are rating scales used by professionals and not filled out by patients themselves33. Compared to other self-rating scales, it can reduce subjective bias. Meanwhile, HAMD and HAMA involve multiple dimensions of assessing anxiety and depression, such as emotions, somatization, sleep, cognition, with broad coverage and comprehensive symptom assessment. Therefore, the accuracy and sensitivity of HAMD and HAMA are reliable. The results were comparable to those previously researched. This indicated that depression and anxiety were relatively prevalent among patients with PNs, representing a significant challenge for this patient population. Therefore, it is imperative to acknowledge the significance of mental health in patients afflicted with PNs. Early identification and timely psychological interventions are of considerable benefit to these patients. This also suggests that it is necessary to consider the mental health status of patients with PNs when optimizing management plans and formulating healthcare policies in the future.
Regarding potential risk factors for depression and anxiety in patients with PNs, our findings indicated that a history of occupational exposure was a significant risk factor for anxiety in patients with PNs. This may be related to the fact that the occupational exposure population is in a potentially carcinogenic environment for a long time and has a higher sensitivity to the risk of malignant progression of abnormal lung lesions. Our statistical occupational exposure factors included chemical exposure, radiation exposure, toxic exposure, and so on. Previous studies have shown that these factors may increase the risk of cancer37,38,39,40. Compared with the general population, these patients tend to have a more direct understanding of the correlation between occupational exposure factors and tumor occurrence41. Their anxiety not only stems from the worry about the nature of the current PNs, but also includes the fear that previous exposure history may lead to disease progression, as well as the worry about the treatment prognosis. This superimposed psychological burden significantly increases the possibility of anxiety. There were no significant differences in depression and anxiety by gender, age, or family history of the tumour. This finding was consistent with the results of the study conducted by Li et al.34. However, Zhuang et al. demonstrated that younger individuals and patients with a family history of tumors exhibited elevated levels of anxiety9while Xiao et al. indicated that females were more likely to have anxiety than males14. Compared with these two studies, our study was conducted in the hospital of TCM. Sample size, regional deviation, and cultural background may be important reasons for the differences in results. In terms of sample size, females accounted for 66.15%, while young people accounted for a lower percentage. Uneven sample sizes and small overall sample sizes may reduce the efficacy of statistical tests42. In the geographical and TCM cultural environment of the study population, young people and women may have a more positive understanding of the clinical outcome of PNs (such as agreeing with the concept of “preventive treatment of disease” in TCM). And patients with a family history of tumor may form stronger psychological resilience due to long-term family care experience. These weaken the association of the above factors with emotional disorders. This also suggests that the combination of TCM and modern medicine may bring more benefits to patients with PNs. Furthermore, Zhuang et al. demonstrated that the number of PNs was a significant positive predictor of depression and anxiety9. However, the results of our study did not indicate a correlation between imaging manifestations (including PNs size and number), classification of hazard levels and depression and anxiety. We speculate that this is related to the distribution characteristics of PNs in the sample. For example, the high proportion of multiple pulmonary nodules (83.85%) and non-malignant signs (86.92%) may reduce the efficiency of the statistical test42. It also reflects the difference in attention to imaging indicators between different study populations. The study population may pay more attention to the doctor’s verbal assessment of PNs risk, rather than purely numerical values of number or diameter. This also explains why imaging findings are not associated with depression and anxiety, suggesting that the psychological state of patients is more directly driven by subjective cognition than objective indicators. Therefore, doctors’ adequate education and communication to patients with PNs in the process of diagnosis and treatment may be an important measure to reduce depression and anxiety.
The presence of clinical symptoms is typically the primary motivation for patients to seek medical attention. The extant literature indicated that subjective symptoms were closely associated with psychological states. It is possible that clinical symptoms may exacerbate depression and anxiety, and conversely, depression and anxiety may precipitate the onset of clinical symptoms43;44. Our results showed that insomnia and loss of appetite were independent factors that contributed to depression and anxiety. Prior research has demonstrated that insomnia increases the risk of depression and anxiety45,46. The regulation of insomnia has been demonstrated to result in the alleviation of depression and anxiety47,48. These findings suggested that insomnia was a key risk factor for depression and anxiety. In addition to insomnia, symptoms of the digestive system were one of the symptom clusters that depression and anxiety patients suffered49. Studies have shown that symptoms of the digestive system were more common in patients with depression and anxiety than in patients without depression and anxiety50. Our research revealed that loss of appetite was an independent influencing factor for depression and anxiety in symptoms of the digestive system, which was consistent with previous studies51,52,53. Furthermore, we found that chest tightness was an independent risk factor for depression. The extant literature indicated that respiratory symptoms exerted an independent influence on the development of anxiety9;43. However, specific symptoms had not been statistically analyzed, which also supported the results of the present study. Overall, these results suggested that we need to pay attention to the mental health of patients with insomnia, chest tightness, and loss of appetite. It was recommended that improvements be made as soon as these symptoms manifest to prevent the development of psychological problems. This will help reduce the incidence of lung cancer. In terms of specific treatment, for insomnia, chest tightness, and loss of appetite, modern medicine can use cognitive behavior therapy, respiratory training guidance, and dietary adjustment, respectively54,55,56,57. Severe cases can be treated with corresponding medications. For patients in a TCM hospital, TCM decoction and acupuncture are also important measures to improve symptoms.
There are several limitations to our study, firstly the cross-sectional design employed did not allow us to ascertain the causal relationship between the variables and depression and anxiety. Furthermore, The sample size of the study was restricted by insufficient funding. A correlation analysis between symptom severity and depression/anxiety severity was not performed. Thirdly, due to financial and temporal constraints, only six common clinical symptoms in patients with PNs were selected for analysis, and a comprehensive and complete symptom analysis was not performed. Other potential symptoms may affect the research results. Finally, this study is a single-center study, and the included population is Chinese people in a TCM hospital, which may have some selection bias. This also limits the universal applicability of the results to a certain extent. However, the results of this study also have certain reference value for other Chinese people and East Asian countries with traditional medical backgrounds (such as South Korea and Japan). This suggests that in the face of people with depression and anxiety, the combination of traditional medicine and modern medicine can be used for education and intervention. In addition, the results of this study found that occupational exposure history was a risk factor for anxiety, which was consistent with modern medical theory. Therefore, the results also have some enlightenment for other races in the context of modern medicine. Due to the shortcomings of this study, it is necessary to further clarify the results of the study through a multicenter, large-sample design, including people of different races, medical systems, and cultural backgrounds. This will also help to more accurately define the applicable boundaries of various risk factors and enhance the clinical transformation value of research results. In addition, multicenter, large-sample longitudinal studies are also necessary in the future to clarify the causal relationship between depression, anxiety, and related factors, as well as the clinical efficacy of psychological interventions.
Conclusion
Depression and anxiety were very common with PNs in TCM hospital. Insomnia and loss of appetite were independent risk factors for depression. The history of occupational exposure, insomnia, loss of appetite, and chest tightness were independent risk factors for anxiety. The results not only provide a target for clinical psychological intervention, but also provide a basis for the optimization of PNs management scheme and healthcare policy making. Medical workers should pay close attention to mood changes in these high-risk patients and help them alleviate their negative emotions. Clinical experts and managers should also consider the mental health of patients with PNs when making schemes and policies, so as to achieve the efficient use of medical resources and the overall improvement of the quality of life of patients.
Data availability
All data generated or analysed during this study are included in this published article.
References
Association, L. C. G. O. & Group, C. L. C. A. Chinese expert consensus on the diagnosis and treatment of pulmonary nodules (2018 Version). Chin. J. Tuberculosis Respiratory Dis. 41, 763–771 (2018).
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E. & Field, J. K. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives. Nat. Rev. Clin. Oncol. 18, 135–151 (2021).
Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395–409 (2011).
Gould, M. K. et al. Recent trends in the identification of incidental pulmonary nodules. Am. J. Respir Crit. Care Med. 192, 1208–1214 (2015).
Tanner, N. T. et al. Management of pulmonary nodules by community pulmonologists: A multicenter observational study. Chest 148, 1405–1414 (2015).
Slatore, C. G. & Wiener, R. S. Pulmonary nodules: A small problem for many, severe distress for some, and how to communicate about it. Chest 153, 1004–1015 (2018).
Hillyer, G. C., Milano, N. & Bulman, W. A. Pulmonary nodules and the psychological harm they can cause: A scoping review. Respir Med. Res. 86, 101121 (2024).
Katsampouris, E. et al. Patients’ experiences of, and psychological responses to, surveillance for pulmonary nodules detected through lung cancer screening. BMJ Open. Respir. Res. 12, (2025).
Zhuang, W. et al. Exploring the psychological profile: A cross-sectional study study of 1,185 patients with pulmonary nodules in an outpatient clinic. J. Thorac. Dis. 14, 4699–4712 (2022).
Wu, J. et al. Investigation on sleep quality and psychological distress in patients with pulmonary nodules. Bmc Psychol. 11, 258 (2023).
Wiener, R. S., Gould, M. K., Woloshin, S., Schwartz, L. M. & Clark, J. A. The thing is not knowing’: patients’ perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect. 18, 355–365 (2015).
Freiman, M. R. et al. Patients’ knowledge, beliefs, and distress associated with detection and evaluation of incidental pulmonary nodules for cancer: results from a multicenter survey. J. Thorac. Oncol. 11, 700–708 (2016).
Koroscil, M. T., Bowman, M. H., Morris, M. J., Skabelund, A. J. & Hersh, A. M. Effect of a pulmonary nodule fact sheet on patient anxiety and knowledge: A quality improvement initiative. Bmj Open. Qual. 7, e437 (2018).
Xiao, R. et al. A cross-sectional study of psychological burden in Chinese patients with pulmonary nodules: prevalence and impact on the management of nodules. Thorac. Cancer. 12, 3150–3156 (2021).
Albert, J. M. Radiation risk from CT: implications for cancer screening. Ajr Am. J. Roentgenol. 201, W81–W87 (2013).
De Berrington, A., Pasqual, E. & Veiga, L. Epidemiological studies of CT scans and cancer risk: the state of the science. Br. J. Radiol. 94, 20210471 (2021).
MacMahon, H. et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner society 2017. Radiology 284, 228–243 (2017).
Martini, N. & Melamed, M. R. Multiple primary lung cancers. J. Thorac. Cardiovasc. Surg. 70, 606–612 (1975).
Leonard, B. E. & Song, C. Stress and the immune system in the etiology of anxiety and depression. Pharmacol. Biochem. Behav. 54, 299–303 (1996).
Martinez, C. A. et al. Prenatal stress, anxiety and depression alter transcripts, proteins and pathways associated with immune responses at the maternal-fetal interfacedagger. Biol. Reprod. 106, 449–462 (2022).
Zhou, Q. et al. China national guideline of classification, diagnosis and treatment for lung nodules (2016 Version). Zhongguo Fei Ai Za Zhi. 19, 793–798 (2016).
Qiu, H. et al. Factors influencing surgical choice and anxiety in patients with pulmonary nodules smaller than 8 mm. J. Thorac. Dis. 15, 6889–6897 (2023).
Wang, X. et al. Prevalence and characteristics of anxiety in patients with unconfirmed pulmonary nodules. Clin. Respir J. 17, 157–164 (2023).
Liu, Y. et al. Study on TCM syndrome characteristics of 419 patients with pulmonary nodules. Guiding J. Traditional Chin. Med. Pharm. 28, 60–63 (2022).
Nie, W., Cheng, M., Wang, L., Ban, C. & Zheng, J. Distribution characteristics of traditional Chinese medicine syndromes in 271 patients with pulmonary nodules in Beijing. World Chin. Med. 17, 2925–2929 (2022).
Zheng, X. Guidelines for Clinical Research of Traditional Chinese Drug Research (China Medical Science, 2002).
HAMILTON, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23, 56–62 (1960).
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I. & Dalrymple, K. Severity classification on the Hamilton depression rating scale. J. Affect. Disord. 150, 384–388 (2013).
Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50–55 (1959).
Matza, L. S., Morlock, R., Sexton, C., Malley, K. & Feltner, D. Identifying ham-a cutoffs for mild, moderate, and severe generalized anxiety disorder. Int. J. Methods Psychiatr Res. 19, 223–232 (2010).
Carrozzino, D., Patierno, C., Fava, G. A. & Guidi, J. The Hamilton rating scales for depression: A critical review of clinimetric properties of different versions. Psychother. Psychosom. 89, 133–150 (2020).
Rodriguez-Seijas, C., Thompson, J. S., Diehl, J. M. & Zimmerman, M. A comparison of the dimensionality of the Hamilton Rating Scale for anxiety and the DSM-5 Anxious-Distress Specifier Interview. Psychiatry Res. 284, 112788 (2020).
Ruan, Y. et al. Application and value of anxiety and depression scale in patients with functional dyspepsia. Bmc Psychol. 12, 244 (2024).
Li, L., Zhao, Y. & Li, H. Assessment of anxiety and depression in patients with incidental pulmonary nodules and analysis of its related impact factors. Thorac. Cancer. 11, 1433–1442 (2020).
Shi, H. Correlation Study between Mental State of Anxiety and Depression and Clinical Features in Patients with Pulmonary Nodules (North China University of Science and Technology, 2022).
Bagby, R. M., Ryder, A. G., Schuller, D. R. & Marshall, M. B. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?? Am. J. Psychiatry. 161, 2163–2177 (2004).
Leiter, A., Veluswamy, R. R. & Wisnivesky, J. P. The global burden of lung cancer: current status and future trends. Nat. Rev. Clin. Oncol. 20, 624–639 (2023).
Richardson, D. B. et al. Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (inworks). Bmj 351, h5359 (2015).
Wan, W. et al. Occupational benzene exposure and lung cancer risk: A pooled analysis of 14 case-control studies. Am. J. Respir Crit. Care Med. 209, 185–196 (2024).
Kwak, K., Kang, D. & Paek, D. Environmental exposure to asbestos and the risk of lung cancer: A systematic review and meta-analysis. Occup. Environ. Med. 79, 207–214 (2022).
Siefert, E., Delva, F., Paris, C., Pairon, J. & Thaon, I. Quality of life in retired workers with past exposure to asbestos. Am. J. Ind. Med. 67, 610–623 (2024).
Wojciechowska, B., Szarmach, A., Michcik, A., Wach, T. & Drogoszewska, B. Association between clinical manifestations in temporomandibular joint disorders and corresponding radiographic findings. J. Clin. Med. 13, (2024).
Leander, M. et al. Impact of anxiety and depression on respiratory symptoms. Respir. Med. 108, 1594–1600 (2014).
Jones, J. D. et al. A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in parkinson’s disease. Clin. Park Relat. Disord. 5, 100104 (2021).
Chellappa, S. L. & Aeschbach, D. Sleep and anxiety: from mechanisms to interventions. Sleep. Med. Rev. 61, 101583 (2022).
Li, L., Wu, C., Gan, Y., Qu, X. & Lu, Z. Insomnia and the risk of depression: A meta-analysis of prospective cohort studies. Bmc Psychiatry. 16, 375 (2016).
Mirchandaney, R., Barete, R. & Asarnow, L. D. Moderators of cognitive behavioral treatment for insomnia on depression and anxiety outcomes. Curr. Psychiatry Rep. 24, 121–128 (2022).
Gebara, M. A. et al. Effect of insomnia treatments on depression: A systematic review and meta-analysis. Depress. Anxiety. 35, 717–731 (2018).
Liu, T. et al. Association of gastrointestinal symptoms with depression and anxiety in recruits: A validation cross-sectional study. Adv. Ther. 41, 3173–3182 (2024).
Xu, H. et al. Female gender and gastrointestinal symptoms, not brain-derived neurotrophic factor, are associated with depression and anxiety in cirrhosis. Hepatol. Res. 47, E64–E73 (2017).
Simmons, W. K. et al. Depression-related increases and decreases in appetite: dissociable patterns of aberrant activity in reward and interoceptive neurocircuitry. Am. J. Psychiatry. 173, 418–428 (2016).
Cosgrove, K. T. et al. Appetite change profiles in depression exhibit differential relationships between systemic inflammation and activity in reward and interoceptive neurocircuitry. Brain Behav. Immun. 83, 163–171 (2020).
Wang, Y., Ye, S., Chen, L., Tang, L. & Fan, D. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression. Sci. Rep. 11, 9119 (2021).
Zhang, A. et al. Cognitive behavioral therapy for primary care depression and anxiety: A secondary meta-analytic review using robust variance estimation in meta-regression. J. Behav. Med. 42, 1117–1141 (2019).
Hertenstein, E. et al. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis. Sleep. Med. Rev. 62, 101597 (2022).
Zampogna, E., Zappa, M., Spanevello, A. & Visca, D. Pulmonary rehabilitation and asthma. Front. Pharmacol. 11, 542 (2020).
Ukovic, B. & Porter, J. Nutrition interventions to improve the appetite of adults undergoing cancer treatment: A systematic review. Support Care Cancer. 28, 4575–4583 (2020).
Funding
This work was supported by the National Key Research and Development Program of China (NO. 2023YFC3503300, NO. 2023YFC3503301), High Level Chinese Medical Hospital Promotion Project (NO. HLCMHPP2023034, NO. HLCMHPP2023085), Project of China Evidence Based Medicine Center for Traditional Chinese Medicine (NO. ZXZL-2), Fundamental Research Funds for the Central Public Welfare Research Institutes (No. ZZ14-YQ-013) and Escort Project (Backbone Talent Training Project) of Guang’anmen Hospital (No. GAMHH9324016).
Author information
Authors and Affiliations
Contributions
KD Cao: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Software, Visualization, Writing – original draft, Writing – review and editing. Z Wang: Data curation, Investigation, Methodology, Project administration, Writing – original draft, Writing – review and editing. T Zhou: Data curation, Investigation, Methodology, Project administration, Writing – original draft, Writing – review and editing. XY Wang: Data curation, Investigation. ZC Wang: Data curation, Investigation. LX Zhang: Data curation, Investigation. BJ Fan: Data curation, Investigation. JL Li: Data curation, Investigation. JW Wang: Conceptualization, Formal analysis, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review and editing. XQ Wang: Conceptualization, Formal analysis, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review and editing. W Hou: Conceptualization, Project administration, Resources, Supervision, Writing – review and editing.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This study was conducted in compliance with the Declaration of Helsinki and obtained ethical approval from the Ethics Committee of Guang’anmen Hospital, China Academy of Chinese Medical Sciences. (reference number: 2021-072-KY; June 21, 2021)
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cao, K., Wang, Z., Zhou, T. et al. Proportion and related factors of depression and anxiety for patients with pulmonary nodules in China: a outpatient-based cross-sectional study. Sci Rep 15, 32029 (2025). https://doi.org/10.1038/s41598-025-17911-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-025-17911-4